These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12957843)

  • 21. A ligand-induced conformational change in apolipoprotein(a) enhances covalent Lp(a) formation.
    Becker L; Webb BA; Chitayat S; Nesheim ME; Koschinsky ML
    J Biol Chem; 2003 Apr; 278(16):14074-81. PubMed ID: 12566443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the lysine binding functions of lipoprotein(a) and plasminogen.
    Hoover-Plow JL; Miles LA; Fless GM; Scanu AM; Plow EF
    Biochemistry; 1993 Dec; 32(49):13681-7. PubMed ID: 8257702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoprotein(a) inhibits collagen-induced aggregation of thrombocytes.
    Gries A; Gries M; Wurm H; Kenner T; Ijsseldijk M; Sixma JJ; Kostner GM
    Arterioscler Thromb Vasc Biol; 1996 May; 16(5):648-55. PubMed ID: 8963722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of apolipoprotein(a) isoform size heterogeneity on the lysine binding function of lipoprotein(a) in early onset coronary artery disease.
    Simó JM; Joven J; Vilella E; Ribas M; Pujana MA; Sundaram IM; Hammel JP; Hoover-Plow JL
    Thromb Haemost; 2001 Mar; 85(3):412-7. PubMed ID: 11307806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the effects of Apo(a) kringle IV-10 and plasminogen kringles on the interactions of lipoprotein(a) with regulatory molecules.
    Xue S; Green MA; LoGrasso PV; Boettcher BR; Madison EL; Curtiss LK; Miles LA
    Thromb Haemost; 1999 Mar; 81(3):428-35. PubMed ID: 10102473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence that the fibrinogen binding domain of Apo(a) is outside the lysine binding site of kringle IV-10: a study involving naturally occurring lysine binding defective lipoprotein(a) phenotypes.
    Klezovitch O; Edelstein C; Scanu AM
    J Clin Invest; 1996 Jul; 98(1):185-91. PubMed ID: 8690792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A role for apolipoprotein(a) in protection of the low-density lipoprotein component of lipoprotein(a) from copper-mediated oxidation.
    Hill BC; Becker L; Anand V; Kusmierczyk A; Marcovina SM; Rahman MN; Gabel BR; Jia Z; Boffa MB; Koschinsky ML
    Arch Biochem Biophys; 2003 Apr; 412(2):186-95. PubMed ID: 12667482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet integrin alpha IIb beta 3 (GPIIb-IIIa) is not implicated in the binding of LDL to intact resting platelets.
    Pedreño J; Fernández R; Cullaré C; Barceló A; Elorza MA; de Castellarnau C
    Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):156-63. PubMed ID: 9012651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein(a) enhances platelet responses to the thrombin receptor-activating peptide SFLLRN.
    Rand ML; Sangrar W; Hancock MA; Taylor DM; Marcovina SM; Packham MA; Koschinsky ML
    Arterioscler Thromb Vasc Biol; 1998 Sep; 18(9):1393-9. PubMed ID: 9743227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ligand-induced conformational change of lipoprotein(a).
    Fless GM; Furbee J; Snyder ML; Meredith SC
    Biochemistry; 1996 Feb; 35(7):2289-98. PubMed ID: 8652569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lp(a) particles mold fibrin-binding properties of apo(a) in size-dependent manner: a study with different-length recombinant apo(a), native Lp(a), and monoclonal antibody.
    Kang C; Dominguez M; Loyau S; Miyata T; Durlach V; Anglés-Cano E
    Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1232-8. PubMed ID: 12117743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipoprotein(a) and thrombocytes: potential mechanisms underlying cardiovascular risk.
    Discepolo W; Wun T; Berglund L
    Pathophysiol Haemost Thromb; 2006; 35(3-4):314-21. PubMed ID: 16877880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A quantitative immunoassay for the lysine-binding function of lipoprotein(a). Application to recombinant apo(a) and lipoprotein(a) in plasma.
    Hoover-Plow JL; Boonmark N; Skocir P; Lawn R; Plow EF
    Arterioscler Thromb Vasc Biol; 1996 May; 16(5):656-64. PubMed ID: 8963723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of active center and lysine binding sites of plasmin in plasmin-induced platelet activation and disaggregation.
    Lu H; Soria C; Li H; Soria J; Lijnen HR; Perrot JY; Caen JP
    Thromb Haemost; 1991 Jan; 65(1):67-72. PubMed ID: 1827215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of mutations in human apolipoprotein(a) kringle 4-37 from the study of the DNA of peripheral blood lymphocytes: relevance to the role of lipoprotein(a) in atherothrombosis.
    Scanu AM
    Am J Cardiol; 1995 Feb; 75(6):58B-61B. PubMed ID: 7863976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxidation of apolipoprotein(a) inhibits kringle-associated lysine binding: the loss of intrinsic protein fluorescence suggests a role for tryptophan residues in the lysine binding site.
    Hermann A; Laws WR; Harpel PC
    Protein Sci; 1997 Nov; 6(11):2324-35. PubMed ID: 9385634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Lipoprotein (a) and stroke].
    Ferraro M; Spagnuolo V; Sprovieri M; Mauro GF
    Minerva Med; 2008 Aug; 99(4):399-409. PubMed ID: 18663347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipoprotein (a) reduces platelet aggregation via apo(a)-mediated decreases in thromboxane A(2)production.
    Barre DE
    Platelets; 1998; 9(2):93-6. PubMed ID: 16793682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional characterization of T7 and T8 of human apolipoprotein (a).
    Trieu VN; McConathy WJ
    Biochem Biophys Res Commun; 1998 Oct; 251(1):356-9. PubMed ID: 9790960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of ADP-induced platelet shape change and aggregation by o-phthalaldehyde: evidence for covalent modification of cysteine and lysine residues.
    Puri RN; Colman RW
    Arch Biochem Biophys; 1991 May; 286(2):419-27. PubMed ID: 1910292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.